| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 08/21/1997 | CA2246371A1 Urogenital and intestinal disorder compositions comprising a substance derived from plant species of the ericaceae family and a lactic acid bacteria growth factor |
| 08/21/1997 | CA2246356A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist |
| 08/21/1997 | CA2246336A1 Combinations, having immunosuppressive effects, containing a cyclooxygenase-2 inhibitor and a leukotriene a4 hydrolase inhibitor |
| 08/21/1997 | CA2246265A1 Combinations having immunosuppressive effects, containing cyclooxygenase-2-inhibitors and 5-lipoxygenase inhibitors |
| 08/21/1997 | CA2245830A1 Beta-thiopropionyl-aminoacid derivatives and their use as beta-lactamase inhibitors |
| 08/21/1997 | CA2243562A1 Parasitic helminth larval thiol specific antioxidant proteins, nucleic acid molecules, and uses thereof |
| 08/20/1997 | EP0790062A1 Remedy for heart diseases |
| 08/20/1997 | EP0789762A1 Methods for the diagnosis of glaucoma |
| 08/20/1997 | EP0789687A1 Ep 2?-receptor agonists as agents for lowering intraocular pressure |
| 08/20/1997 | EP0789586A1 Compounds for the prevention and treatment of helminth infections |
| 08/20/1997 | EP0789578A1 Multicatalytic protease inhibitors |
| 08/20/1997 | EP0789575A1 Peripheral nervous system specific sodium channels, dna encoding therefor, crystallization, x-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof |
| 08/20/1997 | EP0789567A1 A method for treating vascular headaches |
| 08/20/1997 | EP0752813A4 Inhibitors of metazoan parasite proteases |
| 08/20/1997 | CN1157620A Corticotropin-releasing factor-binding-protein inhibitors and their use |
| 08/20/1997 | CN1157570A Intracellular delivery of chemical agents to specific cell type |
| 08/20/1997 | CN1157566A Phosphonates and parathyroid hormone for osteoporosis |
| 08/20/1997 | CN1157565A Method for treatment of osteoporosis using bone active phosphonates and parathyroid hormone |
| 08/19/1997 | US5659045 Retroviral protease inhibiting compounds |
| 08/19/1997 | US5659044 Retroviral protease inhibiting compounds |
| 08/19/1997 | US5658957 Immunostimulating wound healing compositions and method for preparing and using same |
| 08/19/1997 | US5658956 Bioadhesive-wound healing compositions and methods for preparing and using same |
| 08/19/1997 | US5658946 Methods for the treatment of herpes virus infections |
| 08/19/1997 | US5658936 Administering dose of renin-angiotensin system inhibitor which modifies acutely systemic blood pressure by less than ten percent |
| 08/19/1997 | US5658931 Administering a mixture of antiestrogens |
| 08/19/1997 | US5658919 Liquid acetaminophen mixture comprising at least one additional active drug, a suspending system and a taste masking composition |
| 08/19/1997 | US5658907 Compounds and methods for inhibition of HIV and related viruses |
| 08/19/1997 | US5658901 2,3-dihydro-1-(2,2,2,-trifluoroethyl)-2-oxo-5-phenyl-1H-1,4-benzodiazepines |
| 08/19/1997 | US5658895 Anticancer enteral feeding composition |
| 08/19/1997 | US5658581 Histamine antagonist, an interleukin-1 antagonist and/or a TNF alpha antagonist in a cosmetic, pharmaceutical or dermatological composition and composition obtained |
| 08/19/1997 | US5658575 Oil in water emulsion |
| 08/19/1997 | US5658568 Cytotoxic drug therapy |
| 08/19/1997 | US5658556 Applying to the skin the inorganic pigments selected from oxides of titanium, zirconium, zinc, iron, silicon, manganese, aluminum and cerium and mixtures; used for preperation of sun screen lotion or bath oil |
| 08/19/1997 | US5658549 Inhalating drug comprising tetrafluoroethane/1,1,1,2-/ for treating respiratory system disorder |
| 08/19/1997 | CA2007353C Superficial therapeutic system comprising an antineoplastic active substance, particularly 5-fluorouracil |
| 08/14/1997 | WO1997029195A2 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same |
| 08/14/1997 | WO1997028828A1 Composition comprising interleukin-1 inhibitor and controlled release polymer |
| 08/14/1997 | WO1997028826A2 Contraceptive release systems with antibacterial and/or antiviral effect |
| 08/14/1997 | WO1997028825A2 Spermatogenesis control |
| 08/14/1997 | WO1997028823A1 Method of using antacid agent and pharmaceutical preparation containing antacid agent |
| 08/14/1997 | WO1997028822A1 Composition and method for causing photodynamic damage to target cells |
| 08/14/1997 | WO1997028802A1 Inhibition of viral replication |
| 08/14/1997 | DE19606355A1 Kontrazeptive Freisetzungssysteme mit antiviraler und/oder antibakterieller Wirkung Contraceptive delivery systems with antiviral and / or antibacterial effect |
| 08/14/1997 | DE19604773A1 Regulierung der Spermatogenese Regulation of spermatogenesis |
| 08/14/1997 | CA2733866A1 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same |
| 08/14/1997 | CA2539273A1 A fusion protein comprising an interleukin-1 receptor antagonist and uses thereof |
| 08/14/1997 | CA2245920A1 Contraceptive release systems with antibacterial and/or antiviral effect |
| 08/14/1997 | CA2244848A1 Inhibition of viral replication |
| 08/13/1997 | EP0788800A1 Method and kit for inducing immunological tolerance |
| 08/13/1997 | EP0788540A1 Human abh |
| 08/13/1997 | EP0788514A1 Binding agents for treatment of inflammatory, autoimmune or allergic diseases |
| 08/13/1997 | EP0788513A1 Binding agents to cd23 |
| 08/13/1997 | EP0788374A2 Cell-specific gene delivery vehicles |
| 08/13/1997 | EP0788368A1 Therapeutic composition for replacing and/or supplementing body fluids |
| 08/13/1997 | EP0788361A1 Novel compositions based on a synergistic combination of one or more vrd ligands and retinoids |
| 08/13/1997 | EP0788359A1 Compositions useful for the preparation of medicines for treating a variety of intractable disorders |
| 08/13/1997 | EP0788353A1 Ppar gamma antagonists for treating obesity |
| 08/13/1997 | EP0788352A1 Treatment of animals |
| 08/13/1997 | EP0788305A1 Composition for inactivating irritants in fluids |
| 08/13/1997 | CN1156965A Cytokine regulatory agents and method of use in pathologies and conditions associated with altered cytokine levels |
| 08/13/1997 | CN1156961A Formulations and method for providing prolonged local anesthesia |
| 08/13/1997 | CN1156960A Inhalation composition |
| 08/12/1997 | US5656725 Stabilize inappropriate cell proliferation or cell death |
| 08/12/1997 | US5656666 Visibly reducing skin wrinkles |
| 08/12/1997 | US5656665 Method of using quinic acid or quinolactone for treating wrinkles |
| 08/12/1997 | US5656660 Amine or guanidine group-containing tryptase inhibitor |
| 08/12/1997 | US5656652 Compositions containing histamine-H2 -receptor antagonists at low dosage |
| 08/12/1997 | US5656650 Treating hypertension |
| 08/12/1997 | US5656627 Inhibitors of interleukin-1β converting enzyme |
| 08/12/1997 | US5656598 Use of fibroblast growth factors to stimulate bone growth |
| 08/12/1997 | US5656455 Adenylate cyclase stimulating factor |
| 08/12/1997 | US5656273 Administering; treats infection caused by helminth, schistosoma, and metazoan |
| 08/12/1997 | US5655521 Facilitating oxygen delivery through lung by administering fluorocarbon liquid having positive equilibrium coefficient of spreading, introducing breathing gas which mixes with and oxygenates fluorocarbon within lung |
| 08/07/1997 | WO1997028190A1 Cytokine antagonists and agonists |
| 08/07/1997 | WO1997028189A1 Methods for increasing endogenous levels of corticotropin-releasing factor |
| 08/07/1997 | WO1997028186A1 PURIFIED SR-p70 PROTEIN |
| 08/07/1997 | WO1997028149A1 Method for raising hdl cholesterol levels |
| 08/07/1997 | WO1997028137A1 Heterocyclic derivatives as antidiabetic and antiobesity agents |
| 08/07/1997 | WO1997028115A1 Antidiabetic agents |
| 08/07/1997 | WO1997027874A1 Use of angiogenic lipids for vascularizing tissue |
| 08/07/1997 | WO1997027867A1 Protection of hemopoietic cells |
| 08/07/1997 | WO1997027863A1 Combined pharmaceutical preparation containing lhrh-analogous substances and anti-estrogens for treating gynaecological disorders |
| 08/07/1997 | WO1997027859A1 Antitumor agents comprising as the principal agent compounds containing silicon and nitrogen |
| 08/07/1997 | WO1997027857A1 Antidiabetic agents |
| 08/07/1997 | WO1997027848A1 SENSITIZATION OF HER2/neu OVER-EXPRESSING CANCER CELLS TO CHEMOTHERAPEUTIC DRUGS |
| 08/07/1997 | WO1997027847A1 Method of treating diabetes and related disease states |
| 08/07/1997 | WO1997027840A1 Sustained delivery of an active agent using an implantable system |
| 08/07/1997 | DE19703816A1 Additives for injection or infusion solutions, especially of contrast agents |
| 08/07/1997 | CA2245529A1 Antidiabetic agents |
| 08/07/1997 | CA2245524A1 Antidiabetic agents |
| 08/07/1997 | CA2245165A1 Sensitization of her2/neu over-expressing cancer cells to chemotherapeutic drugs |
| 08/07/1997 | CA2245085A1 Protection of hemopoietic cells |
| 08/07/1997 | CA2244831A1 Method of treating diabetes and related disease states |
| 08/07/1997 | CA2244728A1 Use of angiogenic lipids for vascularizing tissue |
| 08/06/1997 | EP0787797A1 Human 5-HT1D receptor (serotonin receptor), process for preparing the same, its uses, antibodies directed against this receptor and transgenics expressing it |
| 08/06/1997 | EP0787741A1 Amylin isolated from pancreatic islet amyloid and pharmaceutical compositions comprising it |
| 08/06/1997 | EP0787197A1 Immortalized lines of endothelial brain cells and therapeutical applications thereof |
| 08/06/1997 | EP0787148A1 Al-1 neurotrophic factor, a ligand for an eph-related tyrosine kinase receptor |
| 08/06/1997 | EP0787145A1 Novel tnf receptor death domain ligand proteins and inhibitors of ligand binding |
| 08/06/1997 | EP0787014A1 Use of flea proteases and protease inhibitors to protect animals from flea infestation |